Moscow, Russia

Lirina Valeryevna Ivanovskaya


Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2004

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Lirina Valeryevna Ivanovskaya: Innovator in Biotechnology

Introduction

Lirina Valeryevna Ivanovskaya is a prominent inventor based in Moscow, Russia. She has made significant contributions to the field of biotechnology, particularly in the area of genetic engineering. Her work focuses on the development of methods for producing essential amino acids through innovative genetic modifications.

Latest Patents

Lirina holds a patent for the "Mutant ilvH gene and method for producing L-valine." This invention provides an isolated DNA molecule that encodes a small subunit of acetohydroxy acid synthase isozyme III. The mutants of this enzyme are free from inhibition by L-valine and can effectively catalyze the conversion of pyruvate to α-acetolactate and α-ketobutyrate and pyruvate to α-aceto-α-hydroxybutyrate. The invention also outlines methods for producing L-valine through the fermentation of bacteria that harbor the novel DNA molecule and express the mutant acetohydroxy acid synthase isozyme III.

Career Highlights

Lirina is currently employed at Ajinomoto Co., Ltd., a leading company in the field of food and biotechnology. Her role involves research and development aimed at enhancing the production of amino acids, which are vital for various industrial applications.

Collaborations

Throughout her career, Lirina has collaborated with notable colleagues, including Vitaliy Arkadyevich Livshits and Vera Georgievna Doroshenko. These collaborations have fostered a productive environment for innovation and advancement in their shared field of expertise.

Conclusion

Lirina Valeryevna Ivanovskaya is a trailblazer in biotechnology, with her innovative patent contributing to the efficient production of L-valine. Her work exemplifies the intersection of genetic engineering and industrial biotechnology, showcasing the potential for scientific advancements to meet global needs.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…